
Sumesh Kaushal
Examiner (ID: 18912)
| Most Active Art Unit | 1633 |
| Art Unit(s) | OPA, 1633, OPIM, 1636 |
| Total Applications | 513 |
| Issued Applications | 223 |
| Pending Applications | 79 |
| Abandoned Applications | 211 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7149542
[patent_doc_number] => 20050120393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Full-length prostate selective polynucleotides and polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/485555
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 30634
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20050120393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485555 | Full-length prostate selective polynucleotides and polypeptides | Aug 1, 2002 | Abandoned |
Array
(
[id] => 483012
[patent_doc_number] => 07220718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-22
[patent_title] => 'Oral treatment of hemophilia'
[patent_app_type] => utility
[patent_app_number] => 10/485696
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 22
[patent_no_of_words] => 18601
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220718.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485696 | Oral treatment of hemophilia | Aug 1, 2002 | Issued |
Array
(
[id] => 575690
[patent_doc_number] => 07452529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-18
[patent_title] => 'Treatment of muscular dystrophy with cord blood cells'
[patent_app_type] => utility
[patent_app_number] => 10/201508
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3389
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/452/07452529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10201508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/201508 | Treatment of muscular dystrophy with cord blood cells | Jul 22, 2002 | Issued |
Array
(
[id] => 6750454
[patent_doc_number] => 20030044974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Method for collecting cells in M phase or G1 phase and method for nuclear transplantation using the cells'
[patent_app_type] => new
[patent_app_number] => 10/196203
[patent_app_country] => US
[patent_app_date] => 2002-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8459
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10196203
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/196203 | Method for collecting cells in M phase or G1 phase and method for nuclear transplantation using the cells | Jul 16, 2002 | Issued |
Array
(
[id] => 421924
[patent_doc_number] => 07273855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-25
[patent_title] => 'Use of prohibitin RNA in treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/190942
[patent_app_country] => US
[patent_app_date] => 2002-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8183
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/273/07273855.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190942 | Use of prohibitin RNA in treatment of cancer | Jul 7, 2002 | Issued |
Array
(
[id] => 609738
[patent_doc_number] => 07151161
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-12-19
[patent_title] => 'Human genes of chromosome 11q13.3'
[patent_app_type] => utility
[patent_app_number] => 10/185047
[patent_app_country] => US
[patent_app_date] => 2002-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 86
[patent_figures_cnt] => 86
[patent_no_of_words] => 31208
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/151/07151161.pdf
[firstpage_image] =>[orig_patent_app_number] => 10185047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/185047 | Human genes of chromosome 11q13.3 | Jun 30, 2002 | Issued |
Array
(
[id] => 6717558
[patent_doc_number] => 20030028906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Gene control'
[patent_app_type] => new
[patent_app_number] => 10/185670
[patent_app_country] => US
[patent_app_date] => 2002-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9120
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20030028906.pdf
[firstpage_image] =>[orig_patent_app_number] => 10185670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/185670 | Gene control | Jun 26, 2002 | Abandoned |
Array
(
[id] => 7161687
[patent_doc_number] => 20050084963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Purification of lineage-specific cells and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/479500
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13363
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084963.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479500 | Purification of lineage-specific cells and uses therefor | May 30, 2002 | Abandoned |
Array
(
[id] => 6831612
[patent_doc_number] => 20030182670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Nucleotide sequence encoding the enzyme I-SceI and the uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/152994
[patent_app_country] => US
[patent_app_date] => 2002-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 23818
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20030182670.pdf
[firstpage_image] =>[orig_patent_app_number] => 10152994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/152994 | Nucleotide sequence encoding the enzyme I-Scel and the uses thereof | May 22, 2002 | Issued |
Array
(
[id] => 7203305
[patent_doc_number] => 20050042738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Carbohydrate-associated proteins'
[patent_app_type] => utility
[patent_app_number] => 10/478519
[patent_app_country] => US
[patent_app_date] => 2002-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47937
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042738.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478519
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478519 | Carbohydrate-associated proteins | May 21, 2002 | Abandoned |
Array
(
[id] => 7313051
[patent_doc_number] => 20040143862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Animal with gene hypoexpression'
[patent_app_type] => new
[patent_app_number] => 10/478466
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13477
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478466
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478466 | Animal with gene hypoexpression | May 20, 2002 | Issued |
Array
(
[id] => 1297556
[patent_doc_number] => 06619719
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-16
[patent_title] => 'Tonneau cover with rotating rear rail and automatic tension control'
[patent_app_type] => B1
[patent_app_number] => 10/150376
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 3985
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/619/06619719.pdf
[firstpage_image] =>[orig_patent_app_number] => 10150376
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/150376 | Tonneau cover with rotating rear rail and automatic tension control | May 16, 2002 | Issued |
Array
(
[id] => 6518422
[patent_doc_number] => 20020192160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Novel human tumor suppressor gene'
[patent_app_type] => new
[patent_app_number] => 10/151736
[patent_app_country] => US
[patent_app_date] => 2002-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9812
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192160.pdf
[firstpage_image] =>[orig_patent_app_number] => 10151736
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/151736 | Human tumor suppressor gene | May 15, 2002 | Issued |
Array
(
[id] => 6323806
[patent_doc_number] => 20020197240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Marrow stem cell (MSC) transplantation for use in tissue and/or organ repair'
[patent_app_type] => new
[patent_app_number] => 10/146092
[patent_app_country] => US
[patent_app_date] => 2002-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14301
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10146092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/146092 | Marrow stem cell (MSC) transplantation for use in tissue and/or organ repair | May 14, 2002 | Abandoned |
Array
(
[id] => 6755323
[patent_doc_number] => 20030003100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'DNA-antibody complexes to enhance gene transfer'
[patent_app_type] => new
[patent_app_number] => 10/143858
[patent_app_country] => US
[patent_app_date] => 2002-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6787
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143858 | DNA-antibody complexes to enhance gene transfer | May 13, 2002 | Abandoned |
Array
(
[id] => 6780185
[patent_doc_number] => 20030051267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Targeted disruption of kinase suppressor of RAS'
[patent_app_type] => new
[patent_app_number] => 10/143122
[patent_app_country] => US
[patent_app_date] => 2002-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10406
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20030051267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143122
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143122 | Targeted disruption of kinase suppressor of RAS | May 8, 2002 | Abandoned |
Array
(
[id] => 6157834
[patent_doc_number] => 20020146806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'CIITA-interacting proteins and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 10/121882
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23015
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121882
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121882 | CIITA-interacting proteins and methods of use therefor | Apr 11, 2002 | Abandoned |
Array
(
[id] => 6047958
[patent_doc_number] => 20020168736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Identification of the gene causing the mouse scurfy phenotype and its human ortholog'
[patent_app_type] => new
[patent_app_number] => 10/115195
[patent_app_country] => US
[patent_app_date] => 2002-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13286
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168736.pdf
[firstpage_image] =>[orig_patent_app_number] => 10115195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/115195 | Identification of the gene causing the mouse scurfy phenotype and its human ortholog | Apr 1, 2002 | Issued |
Array
(
[id] => 6769864
[patent_doc_number] => 20030215804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Novel mechanism for identifying drugs for the treatment of type II diabetes'
[patent_app_type] => new
[patent_app_number] => 10/108953
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17136
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215804.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108953
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108953 | Novel mechanism for identifying drugs for the treatment of type II diabetes | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6687920
[patent_doc_number] => 20030031645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Treatment of idiopathic pulmonary fibrosis using IP-10'
[patent_app_type] => new
[patent_app_number] => 10/104755
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 49922
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031645.pdf
[firstpage_image] =>[orig_patent_app_number] => 10104755
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/104755 | Treatment of idiopathic pulmonary fibrosis using IP-10 | Mar 20, 2002 | Issued |